Table 2 Patient characteristics and risk factor prevalence in patients with and without DVT
|  | Total (n = 102) | DVT (+) (n = 8) | DVT (-) (n = 94) |
|---|---|---|---|
Male gender (n, %) | 59 (57.8) | 6 (75.0) | 53 (56.4) |
ASA (n, %) | 48 (47.1) | 3 (37.5) | 45 (47.9) |
Clopidogrel (n, %) | 14 (13.7) | 0 | 14 (17.9) |
Marcumar (n, %) | 19 (18.6) | 0 | 19 (20.2) |
Heparin (n, %) | 7 (6.9) | 1 (12.5) | 6 (6.4) |
Heart failure NYHA ≥ II | 68 (66.7) | 0 | 68 (72.3) |
Smoker | 15 (14.7) | 3 (37.5) | 12 (12.8) |
Immobility* (n, %) | 54 (52.9) | 6 (75.0) | 48 (51.1) |
Compressions stockings | 14 (13.7) | 1 (12.5) | 13 (13.8) |
Venous insufficiency | 30 (29.4) | 1 (12.5) | 29 (30.9) |
Renal insufficiency (n, %) | 56 (54.9) | 3 (37.5) | 53 (56.4) |
Malignancy 8 (n, %) | 10 (9.8) | 1 (12.5) | 9 (9.6) |
Exsiccosis (n, %) | 21 (20.6) | 2 (25.0) | 19 (20.2) |
Diabetes mellitus (n, %) | 38 (37.3) | 3 (37.5) | 35 (37.2) |